Pricing

AMGEN INC

1 follower · 1 like
THOUSAND OAKS CA
Amgen is based out of Thousand Oaks. Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Its principal products include Aranesp (darbepoetin alfa) and EPOGEN (Epoetin alfa), erythropoietic-stimulating agents (ESAs) that stimulate the production of red blood cells; Neulasta (pegfilgrastim), a pegylated protein, based on the Filgrastim molecule, and NEUPOGEN (Filgrastim), a recombinant-methionyl human granulocyte colony-stimulating factor (G-CSF), both of which selectively stimulate the production of neutrophils (a type of white blood cell that helps the body fight infection), and Enbrel (etanercept), an inhibitor of tumor necrosis factor (TNF), a substance that plays a role in the body's response to inflammatory diseases.Whalewisdom has at least 19 13D filings, 25 13G filings, and 576 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-01-23. The notice included securities offered of Other

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

AMGEN INC
ONE AMGEN CENTER DRIVE
THOUSAND OAKS CA    91320

Business Phone: (805)447-1000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Recent SEC Filings

Filing Date
11-K 2024-06-20
11-K 2024-06-20
S-8 2024-06-12
UPLOAD 2024-05-10
UPLOAD 2024-04-05
CORRESP 2024-04-22
4 2024-06-04
4 2024-06-04
4 2024-06-04
4 2024-06-04

Current 13D/G Holdings

Stock Sector Shares Held Market Value Rank Source Source Date
Neumora Therapeutics Inc. 35,368,653 486,318,979 1 13D 2023-09-27
NewAmsterdam Pharma Company NV FINANCE 4,910,000 116,121,500 2 13G 2022-12-02